Srinivas Emani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Srinivas Emani has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- David Westfall Bates
Brigham and Women's Hospital, Boston, MA, USA
3 shared publications - Angela Rui
Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, United States
2 shared publications - Daniel H. Solomon
Division of Rheumatology, Brigham and Women’s Hospital, Boston, USA
2 shared publications David W Bates
Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham & Women’s Hospital, Harvard Medical School , Boston, Massachusetts, USA
2 shared publicationsDavid W. Bates
Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States
2 shared publications- Emma Stevens
Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA
2 shared publications
Latest Publications
- Open Access
- 30 May 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e67884
User Requirements and Conceptual Design for an Electronic Data Platform for Interhospital Transfer Between Acute Care Hospitals: User-Centered Design Study
Background: The transfer of patients between hospitals, that is, interhospital transfer (IHT), introduces discontinuity of care, including gaps in health information transfer, which may worsen patient outcomes. Objective: This is the first phase of a 5-year research study. Our goals are (1) to understand the gaps in health information exchange (HIE) and the clinician experience in accessing and using the electronic health record (EHR) during IHT and (2) to identify clinician user requirements for the development of an internal EHR solution for IHT. Methods: We used prior work on HIE during IHT, coupled with a user-centered design (UCD) process to engage in discussions with clinical users and gather input on EHR workflow during IHT patient admission and planning. A total of 8 UCD sessions were held between February and July 2023, involving 18 clinicians who interact with the EHR during IHT, including 3 medicine residents, 10 advanced practice providers (APPs), and 5 direct care attendings—all responsible for caring for IHT patients at Brigham and Women’s Hospital Cardiology, Medicine, Oncology, and intensive care unit services. Discussions highlighted facilitators and barriers and suggested improvements for data access and availability at the time of transfer. UCD sessions were recorded, analyzed, and coded by 2 independent reviewers to identify common themes driving suboptimal HIE. User requirements were derived from the sessions with users and iteratively refined throughout the process. Results: Qualitative analysis revealed that a significant number of frontline clinicians experience suboptimal availability of clinical information in the EHR at the time of IHT, including gaps in communication, incomplete data, and inefficient access to clinical data. User requirements emerged from these themes and primarily focused on information prioritization, data accessibility, and workflow and efficiency. Conclusions: Notable levels of missing information and inefficient access to clinical data were reported by end users caring for IHT patients at the time of transfer. Conducting user research to understand the current process of IHT, involving users in conceptual design and information architecture, and generating prototypes for feedback from users can aid in designing a solution that meets user needs. The results of these early UCD activities will be used to develop and implement a data platform to support clinicians during IHT.
- 30 May 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e67884
Open AccessUser Requirements and Conceptual Design for an Electronic Data Platform for Interhospital Transfer Between Acute Care Hospitals: User-Centered Design Study
Background: The transfer of patients between hospitals, that is, interhospital transfer (IHT), introduces discontinuity of care, including gaps in health information transfer, which may worsen patient outcomes. Objective: This is the first phase of a 5-year research study. Our goals are (1) to understand the gaps in health information exchange (HIE) and the clinician experience in accessing and using the electronic health record (EHR) during IHT and (2) to identify clinician user requirements for the development of an internal EHR solution for IHT. Methods: We used prior work on HIE during IHT, coupled with a user-centered design (UCD) process to engage in discussions with clinical users and gather input on EHR workflow during IHT patient admission and planning. A total of 8 UCD sessions were held between February and July 2023, involving 18 clinicians who interact with the EHR during IHT, including 3 medicine residents, 10 advanced practice providers (APPs), and 5 direct care attendings—all responsible for caring for IHT patients at Brigham and Women’s Hospital Cardiology, Medicine, Oncology, and intensive care unit services. Discussions highlighted facilitators and barriers and suggested improvements for data access and availability at the time of transfer. UCD sessions were recorded, analyzed, and coded by 2 independent reviewers to identify common themes driving suboptimal HIE. User requirements were derived from the sessions with users and iteratively refined throughout the process. Results: Qualitative analysis revealed that a significant number of frontline clinicians experience suboptimal availability of clinical information in the EHR at the time of IHT, including gaps in communication, incomplete data, and inefficient access to clinical data. User requirements emerged from these themes and primarily focused on information prioritization, data accessibility, and workflow and efficiency. Conclusions: Notable levels of missing information and inefficient access to clinical data were reported by end users caring for IHT patients at the time of transfer. Conducting user research to understand the current process of IHT, involving users in conceptual design and information architecture, and generating prototypes for feedback from users can aid in designing a solution that meets user needs. The results of these early UCD activities will be used to develop and implement a data platform to support clinicians during IHT.
- Open Access
- 23 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Development of an Electronic Data Platform for Interhospital Transfer Between Acute Care Hospitals: User Requirements and Conceptual Design (Preprint)
BACKGROUND The transfer of patients between hospitals, i.e., interhospital transfer (IHT), introduces discontinuity of care including gaps in health information transfer, which may worsen patient outcomes. OBJECTIVE This is this first phase of a five-year research study. Our goals are (1) to understand the gaps in health information exchange (HIE) and the clinician experience in accessing and using the electronic health record (EHR) during IHT; and (2) to identify clinician user requirements for development of an internal EHR solution for IHT. METHODS We utilized prior work on health information exchange (HIE) during IHT coupled with a user-centered design (UCD) process to engage discussions with clinical users and gather input on EHR workflow during IHT patient admission and planning. Eight UCD sessions were held between 2/2023-7/2023, involving 18 clinicians who interact with the EHR during IHT, including 3 medicine residents, 10 advanced practice providers and 5 direct care attendings – all responsible for caring for IHT patients at Brigham and Women’s Cardiology, Medicine, Oncology and ICU services. Discussions highlighted facilitators and barriers, and suggested improvements for data access and availability at the time of transfer. UCD sessions were recorded, analyzed, and coded by two independent reviewers to identify common themes driving sub-optimal HIE. User requirements were derived from the sessions with users and iteratively refined throughout the process. RESULTS Qualitative analysis revealed that a significant number of frontline clinicians experience suboptimal availability of clinical information in the EHR at the time of IHT, including gaps in communication, incomplete data, and inefficient access to clinical data. User requirements emerged from these themes and primarily focused on information prioritization, data accessibility and workflow and efficiency. CONCLUSIONS Notable levels of missing information and inefficient access to clinical data were reported by end-users caring for IHT patients at time of transfer. Conducting user research to understand the current process of IHT, involving users in conceptual design and information architecture, and generating prototypes for feedback from users can aid in designing a solution that meets user needs. Results of these early UCD activities will be used to develop and implement a data platform to support clinicians during IHT. CLINICALTRIAL
- 23 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDevelopment of an Electronic Data Platform for Interhospital Transfer Between Acute Care Hospitals: User Requirements and Conceptual Design (Preprint)
BACKGROUND The transfer of patients between hospitals, i.e., interhospital transfer (IHT), introduces discontinuity of care including gaps in health information transfer, which may worsen patient outcomes. OBJECTIVE This is this first phase of a five-year research study. Our goals are (1) to understand the gaps in health information exchange (HIE) and the clinician experience in accessing and using the electronic health record (EHR) during IHT; and (2) to identify clinician user requirements for development of an internal EHR solution for IHT. METHODS We utilized prior work on health information exchange (HIE) during IHT coupled with a user-centered design (UCD) process to engage discussions with clinical users and gather input on EHR workflow during IHT patient admission and planning. Eight UCD sessions were held between 2/2023-7/2023, involving 18 clinicians who interact with the EHR during IHT, including 3 medicine residents, 10 advanced practice providers and 5 direct care attendings – all responsible for caring for IHT patients at Brigham and Women’s Cardiology, Medicine, Oncology and ICU services. Discussions highlighted facilitators and barriers, and suggested improvements for data access and availability at the time of transfer. UCD sessions were recorded, analyzed, and coded by two independent reviewers to identify common themes driving sub-optimal HIE. User requirements were derived from the sessions with users and iteratively refined throughout the process. RESULTS Qualitative analysis revealed that a significant number of frontline clinicians experience suboptimal availability of clinical information in the EHR at the time of IHT, including gaps in communication, incomplete data, and inefficient access to clinical data. User requirements emerged from these themes and primarily focused on information prioritization, data accessibility and workflow and efficiency. CONCLUSIONS Notable levels of missing information and inefficient access to clinical data were reported by end-users caring for IHT patients at time of transfer. Conducting user research to understand the current process of IHT, involving users in conceptual design and information architecture, and generating prototypes for feedback from users can aid in designing a solution that meets user needs. Results of these early UCD activities will be used to develop and implement a data platform to support clinicians during IHT. CLINICALTRIAL
- 3 March 2023
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 30 (5) , 995-999
Racism and Electronic Health Records (EHRs): Perspectives for research and practice
Informatics researchers and practitioners have started exploring racism related to the implementation and use of electronic health records (EHRs). While this work has begun to expose structural racism which is a fundamental driver of racial and ethnic disparities, there is a lack of inclusion of concepts of racism in this work. This perspective provides a classification of racism at 3 levels—individual, organizational, and structural—and offers recommendations for future research, practice, and policy. Our recommendations include the need to capture and use structural measures of social determinants of health to address structural racism, intersectionality as a theoretical framework for research, structural competency training, research on the role of prejudice and stereotyping in stigmatizing documentation in EHRs, and actions to increase the diversity of private sector informatics workforce and participation of minority scholars in specialty groups. Informaticians have an ethical and moral obligation to address racism, and private and public sector organizations have a transformative role in addressing equity and racism associated with EHR implementation and use.
- 3 March 2023
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 30 (5) , 995-999
Racism and Electronic Health Records (EHRs): Perspectives for research and practice
Informatics researchers and practitioners have started exploring racism related to the implementation and use of electronic health records (EHRs). While this work has begun to expose structural racism which is a fundamental driver of racial and ethnic disparities, there is a lack of inclusion of concepts of racism in this work. This perspective provides a classification of racism at 3 levels—individual, organizational, and structural—and offers recommendations for future research, practice, and policy. Our recommendations include the need to capture and use structural measures of social determinants of health to address structural racism, intersectionality as a theoretical framework for research, structural competency training, research on the role of prejudice and stereotyping in stigmatizing documentation in EHRs, and actions to increase the diversity of private sector informatics workforce and participation of minority scholars in specialty groups. Informaticians have an ethical and moral obligation to address racism, and private and public sector organizations have a transformative role in addressing equity and racism associated with EHR implementation and use.
- Open Access
- 29 July 2022
- Published by Georg Thieme Verlag KG in ACI Open
- Vol. 06 (02) , e66-e75
Physicians' Perceptions and Expectations of an Artificial Intelligence-Based Clinical Decision Support System in Cancer Care in an Underserved Setting
Objectives Artificial intelligence (AI) tools are being increasingly incorporated into health care. However, few studies have evaluated users' expectations of such tools, prior to implementation, specifically in an underserved setting. Methods We conducted a qualitative research study employing semistructured interviews of physicians at The Instituto do Câncer do Ceará, Fortaleza, Brazil. The interview guide focused on anticipated, perceived benefits and challenges of using an AI-based clinical decision support system tool, Watson for Oncology. We recruited physician oncologists, working full or part-time, without prior experience with any AI-based tool. The interviews were taped and transcribed in Portuguese and then translated into English. Thematic analysis using the constant comparative approach was performed. Results Eleven oncologists participated in the study. The following overarching themes and subthemes emerged from the analysis of interview transcripts: theme-1, “general context” including (1) current setting, workload, and patient population and (2) existing challenges in cancer treatment, and theme-2, “perceptions around the potential use of an AI-based tool,” including (1) perceived benefits and (2) perceived challenges. Physicians expected that the implementation of an AI-based tool would result in easy access to the latest clinical recommendations, facilitate standardized cancer care, and allow it to be delivered with greater confidence and efficiency. Participants had several concerns such as availability of innovative treatments in resource-poor settings, treatment acceptance, trust, physician autonomy, and workflow disruptions. Conclusion This study provides physicians' anticipated perspectives, both benefits and challenges, about the use of an AI-based tool in cancer treatment in a resource-limited setting. The study was performed in compliance with the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects and was reviewed and approved by the ICC Review Board. * Equal contributor first authors. Received: 25 January 2022 Accepted: 23 May 2022 Article published online: 30 July 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 29 July 2022
- Published by Georg Thieme Verlag KG in ACI Open
- Vol. 06 (02) , e66-e75
Open AccessPhysicians' Perceptions and Expectations of an Artificial Intelligence-Based Clinical Decision Support System in Cancer Care in an Underserved Setting
Objectives Artificial intelligence (AI) tools are being increasingly incorporated into health care. However, few studies have evaluated users' expectations of such tools, prior to implementation, specifically in an underserved setting. Methods We conducted a qualitative research study employing semistructured interviews of physicians at The Instituto do Câncer do Ceará, Fortaleza, Brazil. The interview guide focused on anticipated, perceived benefits and challenges of using an AI-based clinical decision support system tool, Watson for Oncology. We recruited physician oncologists, working full or part-time, without prior experience with any AI-based tool. The interviews were taped and transcribed in Portuguese and then translated into English. Thematic analysis using the constant comparative approach was performed. Results Eleven oncologists participated in the study. The following overarching themes and subthemes emerged from the analysis of interview transcripts: theme-1, “general context” including (1) current setting, workload, and patient population and (2) existing challenges in cancer treatment, and theme-2, “perceptions around the potential use of an AI-based tool,” including (1) perceived benefits and (2) perceived challenges. Physicians expected that the implementation of an AI-based tool would result in easy access to the latest clinical recommendations, facilitate standardized cancer care, and allow it to be delivered with greater confidence and efficiency. Participants had several concerns such as availability of innovative treatments in resource-poor settings, treatment acceptance, trust, physician autonomy, and workflow disruptions. Conclusion This study provides physicians' anticipated perspectives, both benefits and challenges, about the use of an AI-based tool in cancer treatment in a resource-limited setting. The study was performed in compliance with the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects and was reviewed and approved by the ICC Review Board. * Equal contributor first authors. Received: 25 January 2022 Accepted: 23 May 2022 Article published online: 30 July 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 7 April 2022
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 8 (2) , e31461
Physicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries
As technology continues to improve, health care systems have the opportunity to use a variety of innovative tools for decision-making, including artificial intelligence (AI) applications. However, there has been little research on the feasibility and efficacy of integrating AI systems into real-world clinical practice, especially from the perspectives of clinicians who use such tools. In this paper, we review physicians’ perceptions of and satisfaction with an AI tool, Watson for Oncology, which is used for the treatment of cancer. Watson for Oncology has been implemented in several different settings, including Brazil, China, India, South Korea, and Mexico. By focusing on the implementation of an AI-based clinical decision support system for oncology, we aim to demonstrate how AI can be both beneficial and challenging for cancer management globally and particularly for low-middle–income countries. By doing so, we hope to highlight the need for additional research on user experience and the unique social, cultural, and political barriers to the successful implementation of AI in low-middle–income countries for cancer care.
- 7 April 2022
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 8 (2) , e31461
Open AccessPhysicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries
As technology continues to improve, health care systems have the opportunity to use a variety of innovative tools for decision-making, including artificial intelligence (AI) applications. However, there has been little research on the feasibility and efficacy of integrating AI systems into real-world clinical practice, especially from the perspectives of clinicians who use such tools. In this paper, we review physicians’ perceptions of and satisfaction with an AI tool, Watson for Oncology, which is used for the treatment of cancer. Watson for Oncology has been implemented in several different settings, including Brazil, China, India, South Korea, and Mexico. By focusing on the implementation of an AI-based clinical decision support system for oncology, we aim to demonstrate how AI can be both beneficial and challenging for cancer management globally and particularly for low-middle–income countries. By doing so, we hope to highlight the need for additional research on user experience and the unique social, cultural, and political barriers to the successful implementation of AI in low-middle–income countries for cancer care.
- Open Access
- 22 June 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Physicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries (Preprint)
UNSTRUCTURED As technology continues to improve, health care systems have the opportunity to use a variety of innovative tools for decision-making, including artificial intelligence (AI) applications. However, there has been little research on the feasibility and efficacy of integrating AI systems into real-world clinical practice, especially from the perspectives of clinicians who use such tools. In this paper, we review physicians’ perceptions of and satisfaction with an AI tool, Watson for Oncology, which is used for the treatment of cancer. Watson for Oncology has been implemented in several different settings, including Brazil, China, India, South Korea, and Mexico. By focusing on the implementation of an AI-based clinical decision support system for oncology, we aim to demonstrate how AI can be both beneficial and challenging for cancer management globally and particularly for low-middle–income countries. By doing so, we hope to highlight the need for additional research on user experience and the unique social, cultural, and political barriers to the successful implementation of AI in low-middle–income countries for cancer care.
- 22 June 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPhysicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries (Preprint)
UNSTRUCTURED As technology continues to improve, health care systems have the opportunity to use a variety of innovative tools for decision-making, including artificial intelligence (AI) applications. However, there has been little research on the feasibility and efficacy of integrating AI systems into real-world clinical practice, especially from the perspectives of clinicians who use such tools. In this paper, we review physicians’ perceptions of and satisfaction with an AI tool, Watson for Oncology, which is used for the treatment of cancer. Watson for Oncology has been implemented in several different settings, including Brazil, China, India, South Korea, and Mexico. By focusing on the implementation of an AI-based clinical decision support system for oncology, we aim to demonstrate how AI can be both beneficial and challenging for cancer management globally and particularly for low-middle–income countries. By doing so, we hope to highlight the need for additional research on user experience and the unique social, cultural, and political barriers to the successful implementation of AI in low-middle–income countries for cancer care.
- Open Access
- 27 May 2020
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 4 (3) , e15158
Improving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study
Background: Patient-reported outcomes (PROs) for chronic disease management can be integrated into the routine workflow by leveraging mobile technology. Objective: The objective of our study was to describe the process of our quality improvement (QI) efforts using tablets for PRO collection in a busy, academic rheumatology practice to support a treat-to-target (TTT) approach for rheumatoid arthritis (RA) management. Methods: Our QI team designed a process for routine collection of PROs for RA patients at the Arthritis Center, employing information technology and an electronic medical record (EMR) system. Patients received a tablet at the clinic check-in desk to complete the Routine Assessment of Patient Index Data 3 (RAPID3) survey, a validated RA PRO. RAPID3 scores were uploaded to the EMR in real time and available for use in shared decision making during routine office visits. Weekly data were collected on RAPID3 completion rates and shared with front desk staff and medical assistants to drive improvement. Patients in our patient family advisory council and focus groups provided informal feedback on the process. Results: From May 1, 2017, to January 31, 2019, a total of 4233 RAPID3 surveys were completed by 1691 patients. The mean age of patients was 63 (SD 14) years; 84.00% (1420/1691) of the patients were female, and 83.00% (1403/1691) of the patients were white. The rates of RAPID3 completion increased from 14.3% (58/405) in May 2017 to 68.00% (254/376) in September 2017 and were sustained over time through January 2019. Informal feedback from patients was positive and negative, relating to the usability of the tablet and the way rheumatologists used and explained the RAPID3 data in shared decision making during the office visit. Conclusions: We designed a sustainable and reliable process for collecting PROs from patients with RA in the waiting room and integrated these data through the EMR during office visits.
- 27 May 2020
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 4 (3) , e15158
Open AccessImproving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study
Background: Patient-reported outcomes (PROs) for chronic disease management can be integrated into the routine workflow by leveraging mobile technology. Objective: The objective of our study was to describe the process of our quality improvement (QI) efforts using tablets for PRO collection in a busy, academic rheumatology practice to support a treat-to-target (TTT) approach for rheumatoid arthritis (RA) management. Methods: Our QI team designed a process for routine collection of PROs for RA patients at the Arthritis Center, employing information technology and an electronic medical record (EMR) system. Patients received a tablet at the clinic check-in desk to complete the Routine Assessment of Patient Index Data 3 (RAPID3) survey, a validated RA PRO. RAPID3 scores were uploaded to the EMR in real time and available for use in shared decision making during routine office visits. Weekly data were collected on RAPID3 completion rates and shared with front desk staff and medical assistants to drive improvement. Patients in our patient family advisory council and focus groups provided informal feedback on the process. Results: From May 1, 2017, to January 31, 2019, a total of 4233 RAPID3 surveys were completed by 1691 patients. The mean age of patients was 63 (SD 14) years; 84.00% (1420/1691) of the patients were female, and 83.00% (1403/1691) of the patients were white. The rates of RAPID3 completion increased from 14.3% (58/405) in May 2017 to 68.00% (254/376) in September 2017 and were sustained over time through January 2019. Informal feedback from patients was positive and negative, relating to the usability of the tablet and the way rheumatologists used and explained the RAPID3 data in shared decision making during the office visit. Conclusions: We designed a sustainable and reliable process for collecting PROs from patients with RA in the waiting room and integrated these data through the EMR during office visits.
- Open Access
- 1 August 2019
- Published by Elsevier in The Joint Commission Journal on Quality and Patient Safety
- Vol. 45 (8) , 552-557
Ambulatory Safety Nets to Reduce Missed and Delayed Diagnoses of Cancer
- 1 August 2019
- Published by Elsevier in The Joint Commission Journal on Quality and Patient Safety
- Vol. 45 (8) , 552-557
Open AccessAmbulatory Safety Nets to Reduce Missed and Delayed Diagnoses of Cancer
- Open Access
- 24 June 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Improving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study (Preprint)
BACKGROUND Patient-reported outcomes (PROs) for chronic disease management can be integrated into the routine workflow by leveraging mobile technology. OBJECTIVE The objective of our study was to describe the process of our quality improvement (QI) efforts using tablets for PRO collection in a busy, academic rheumatology practice to support a treat-to-target (TTT) approach for rheumatoid arthritis (RA) management. METHODS Our QI team designed a process for routine collection of PROs for RA patients at the Arthritis Center, employing information technology and an electronic medical record (EMR) system. Patients received a tablet at the clinic check-in desk to complete the Routine Assessment of Patient Index Data 3 (RAPID3) survey, a validated RA PRO. RAPID3 scores were uploaded to the EMR in real time and available for use in shared decision making during routine office visits. Weekly data were collected on RAPID3 completion rates and shared with front desk staff and medical assistants to drive improvement. Patients in our patient family advisory council and focus groups provided informal feedback on the process. RESULTS From May 1, 2017, to January 31, 2019, a total of 4233 RAPID3 surveys were completed by 1691 patients. The mean age of patients was 63 (SD 14) years; 84.00% (1420/1691) of the patients were female, and 83.00% (1403/1691) of the patients were white. The rates of RAPID3 completion increased from 14.3% (58/405) in May 2017 to 68.00% (254/376) in September 2017 and were sustained over time through January 2019. Informal feedback from patients was positive and negative, relating to the usability of the tablet and the way rheumatologists used and explained the RAPID3 data in shared decision making during the office visit. CONCLUSIONS We designed a sustainable and reliable process for collecting PROs from patients with RA in the waiting room and integrated these data through the EMR during office visits.
- 24 June 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImproving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study (Preprint)
BACKGROUND Patient-reported outcomes (PROs) for chronic disease management can be integrated into the routine workflow by leveraging mobile technology. OBJECTIVE The objective of our study was to describe the process of our quality improvement (QI) efforts using tablets for PRO collection in a busy, academic rheumatology practice to support a treat-to-target (TTT) approach for rheumatoid arthritis (RA) management. METHODS Our QI team designed a process for routine collection of PROs for RA patients at the Arthritis Center, employing information technology and an electronic medical record (EMR) system. Patients received a tablet at the clinic check-in desk to complete the Routine Assessment of Patient Index Data 3 (RAPID3) survey, a validated RA PRO. RAPID3 scores were uploaded to the EMR in real time and available for use in shared decision making during routine office visits. Weekly data were collected on RAPID3 completion rates and shared with front desk staff and medical assistants to drive improvement. Patients in our patient family advisory council and focus groups provided informal feedback on the process. RESULTS From May 1, 2017, to January 31, 2019, a total of 4233 RAPID3 surveys were completed by 1691 patients. The mean age of patients was 63 (SD 14) years; 84.00% (1420/1691) of the patients were female, and 83.00% (1403/1691) of the patients were white. The rates of RAPID3 completion increased from 14.3% (58/405) in May 2017 to 68.00% (254/376) in September 2017 and were sustained over time through January 2019. Informal feedback from patients was positive and negative, relating to the usability of the tablet and the way rheumatologists used and explained the RAPID3 data in shared decision making during the office visit. CONCLUSIONS We designed a sustainable and reliable process for collecting PROs from patients with RA in the waiting room and integrated these data through the EMR during office visits.
- Open Access
- 1 July 2018
- Published by BMJ in BMJ Health & Care Informatics
- Vol. 25 (3) , 149-157
Perceptions of adopters versus non-adopters of a patient portal: an application of diffusion of innovation theory
Background: Patient portals have emerged as an important tool through which patients can access online health information and engage in their health care. However, we know little about how patients perceive portals and whether patient perceptions might influence portal adoption. Objective: Apply the diffusion of innovation (DOI) theory to assess perceptions of adopters and non-adopters of a patient portal. Methods: We conducted a cross-sectional survey of adopters and non-adopters of the portal. Our survey consisted of perceived attributes from the DOI theory, socio-demographic characteristics and patient perceptions of technology adoption. Results: Three factors representing perceived attributes from DOI theory accounted for 73% of the variance in the data: Factor 1 – Relative Advantage (27%); Factor 2 – Ease of Use (24%) and Factor 3 – Trialability (22%). Adopters perceived greater Relative Advantage [mean (SD)] = 3.8 (0.71) versus 3.2 (0.89), p < 0.001, Ease of Use = 4.1 (0.71) versus 3.3 (0.95), p < 0.001 and Trialability = 4.0 (0.57) versus 3.4 (0.99), p < 0.001 than non-adopters. In multivariate modelling, age [OR = 3.75, 95% CI: (2.17, 6.46), p < 0.001] and income [OR = 1.87, 95% CI: (1.17, 3.00), p < 0.01] predicted adoption of the portal. Among DOI factors, Relative advantage predicted adoption of the portal [OR = 1.48, 95% CI: (1.03, 2.11), p < 0.05]. Conclusion: Patients will adopt a patient portal if they perceive it to offer a relative advantage over existing practices such as telephoning or visiting the doctor’s office. Organisations seeking to increase the adoption of patient portals should implement strategies to promote the relative advantage of portals as, for example, through posters in waiting and exam rooms. A digital divide in the adoption of patient portals may exist with respect to age and income.
- 1 July 2018
- Published by BMJ in BMJ Health & Care Informatics
- Vol. 25 (3) , 149-157
Open AccessPerceptions of adopters versus non-adopters of a patient portal: an application of diffusion of innovation theory
Background: Patient portals have emerged as an important tool through which patients can access online health information and engage in their health care. However, we know little about how patients perceive portals and whether patient perceptions might influence portal adoption. Objective: Apply the diffusion of innovation (DOI) theory to assess perceptions of adopters and non-adopters of a patient portal. Methods: We conducted a cross-sectional survey of adopters and non-adopters of the portal. Our survey consisted of perceived attributes from the DOI theory, socio-demographic characteristics and patient perceptions of technology adoption. Results: Three factors representing perceived attributes from DOI theory accounted for 73% of the variance in the data: Factor 1 – Relative Advantage (27%); Factor 2 – Ease of Use (24%) and Factor 3 – Trialability (22%). Adopters perceived greater Relative Advantage [mean (SD)] = 3.8 (0.71) versus 3.2 (0.89), p < 0.001, Ease of Use = 4.1 (0.71) versus 3.3 (0.95), p < 0.001 and Trialability = 4.0 (0.57) versus 3.4 (0.99), p < 0.001 than non-adopters. In multivariate modelling, age [OR = 3.75, 95% CI: (2.17, 6.46), p < 0.001] and income [OR = 1.87, 95% CI: (1.17, 3.00), p < 0.01] predicted adoption of the portal. Among DOI factors, Relative advantage predicted adoption of the portal [OR = 1.48, 95% CI: (1.03, 2.11), p < 0.05]. Conclusion: Patients will adopt a patient portal if they perceive it to offer a relative advantage over existing practices such as telephoning or visiting the doctor’s office. Organisations seeking to increase the adoption of patient portals should implement strategies to promote the relative advantage of portals as, for example, through posters in waiting and exam rooms. A digital divide in the adoption of patient portals may exist with respect to age and income.